Lario Therapeutics

Neurosciences

This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.

Neumirna Therapeutics

This biotechnology company develops microRNA-based therapies to treat patients with neurological disorders, including drug-resistant epilepsy and Parkinson's disease.

EpilepsyGTx

This company develops precision gene therapies for patients with focal refractory epilepsy to provide seizure freedom.

Corlieve Therapeutics

The company develops gene therapies for patients with refractory temporal lobe epilepsy and other severe neurological disorders.

Arvelle Therapeutics

This biopharmaceutical company develops and commercialises antiepileptic medicines to treat patients suffering from central nervous system disorders.

Encoded Therapeutics

This biotechnology company develops precision genetic medicines for patients with severe neurological disorders, including Dravet syndrome.

iQure Pharma

This clinical-stage biotech company develops astrocyte-targeted therapeutics to restore glutamate balance for patients with central nervous system disorders such as epilepsy and Parkinson's disease.

Navion

This biotechnology company develops precision sodium channel medicines for patients with neurological conditions including genetic epilepsy and chronic neuropathic pain.